肠溶胶囊
- 网络Enteric coated capsule;Enteric Capsules;Intestine-sol Capsule
![肠溶胶囊](../cache/1194966.jpg)
-
国产去羟肌苷肠溶胶囊在中国健康男青年体内药物动力学研究
Pharmacokinetics of domestic didanosine enteric capsules in healthy Chinese young men
-
目的评价2种泮托拉唑肠溶胶囊的生物等效性。
Objective To evaluate the bioequivalence of Pantoprazole enteric capsules .
-
ml-1。奥美拉唑肠溶胶囊的相对生物利用度为(111.1±58.1)%。
The relative bioavailability of omeprazole enteric-coated capsules was ( 111.1 ± 58.1 ) % .
-
方法20名志愿者单剂量口服150mg的罗红霉素肠溶胶囊,采用LC-MS法测定其血清中罗红霉素浓度。
Methods 20 male healthy subjects received a single dose of 150 mg roxithromycin enterosoluble capsules .
-
采用GC法对包合物肠溶胶囊进行含量测定,研究表明以上所用定量方法准确、简便、可靠,可作为控制本品内在质量的指标。
For closure by GC methods that are intestines dissolving capsule content determination , studies show that more quantitative method used simple , reliable , accurate , and can be used as a control this product immanent quality indicators .
-
~(125)I-PEG-SOD(PEG6000)肠溶胶囊在家兔体内的药动学
The pharmacokinetics of ~ ( 125 ) I - PEG - SOD ( PEG6000 ) enteric-coated capsuls in rabbits
-
方法10例男性健康志愿者分别空腹口服国产奥美拉唑肠溶胶囊和洛赛克肠溶胶囊(对照品)20mg。
METHOD Ten male healthy volunteers orally took domestic omeprazole entero dissolving capsules and Losec entero dissolving capsules ( used as reference ) 20 mg respectively .
-
方法:80例轻中度呼吸道感染患者用红霉素肠溶胶囊500mg,bid,疗程5~7d。
Methods : 80 patients with mild or moderate respiratory tract infection were treated with erythromycin in enteric coated capsule at a dosage of 500 mg b. i. d PO for 5 ~ 7 days .
-
目的:测定125I-PEG-SOD肠溶胶囊单次灌胃后不同时间家兔全血中的放射性计数,计算其药动学参数。
Objective : To calculate the pharmacokinetic parameters by measuring the radiation in blood at different time after the 125I - PEG - SOD enteric-coated capsuls were fed on different group of rabbits .
-
复方谷氨酰胺肠溶胶囊中L-谷氨酰胺释放度的测定
Determination of drug release of glutamine in its enteric coated capsules
-
奥美拉唑原料及其肠溶胶囊有关物质检查方法的研究
Determination of Related Substance in Omeprazole and Its Enteric - coated Capsules
-
目的:建立奥沙普嗪肠溶胶囊的荧光测定法。
To establish fluorescent method for the determination of oxaprozin enteric-coated capsules .
-
泮托拉唑钠肠溶胶囊处方工艺及稳定性研究
Study on Preparation and Stability of Pantoprazole Sodium Enteric-Coated Capsules
-
丙硫氧嘧啶肠溶胶囊人体相对生物利用度研究
Study on the Relative Bioavailability of Propylthiouracil Enteric Coated Capsules
-
酮洛芬肠溶胶囊的溶出速率测定
Determination of Dissolution Rate of Ketoprofen Enteric Coating Capsules
-
双歧杆菌微囊肠溶胶囊的制备
Preparation of bifidobacterial microencapsules in completely closed capsules
-
萘普生肠溶胶囊人体药物动力学和相对生物利用度
Pharmacokinetics and relative bioavailability of naproxen enteric capsules
-
盐酸度洛西汀肠溶胶囊治疗抑郁症的疗效和安全性
Efficacy and safety of duloxetine with fluoxetine in the treatment of major depressive disorder
-
不同厂家奥美拉唑肠溶胶囊的体外溶出度比较
Comparison of in Vitro Dissolution of Omeprazole Enteric-coated Capsules from Seven Different Pharmaceutical Factories
-
硫普罗宁肠溶胶囊的人体生物等效性研究
Bioequivalence of tiopronin enteric capsules in healthy volunteers
-
国产红霉素肠溶胶囊在健康志愿者的相对生物利用度
Bioequivalence of erythromycin enteric-coated capsules in healthy volunteers
-
红霉素肠溶胶囊治疗呼吸道感染80例
Enteric-coated Capsule of Erythromycin in the Treatment of 80 Cases of Respiratory Tract Infections
-
前言:目的:研究泮托拉唑钠肠溶胶囊工艺处方。
Objective : To optimize the formulation and preparation of Pantoprazole Sodium Enteric-Coated Capsules .
-
麦迪霉素肠溶胶囊剂生物利用度的测定
A Measurement on Bioavailability of Midecamycin Capsules
-
目的建立紫外-可见分光光度法测定兰索拉唑肠溶胶囊体外释放度的方法。
Objective To establish a method of release of Lansoprazole enteric-coated capsule by UV method .
-
分光光度法测定红霉素肠溶胶囊溶出度的研究
Dissolution of Enteric-coated Erythromycin Capsules by Spectrophotometry
-
高效液相色谱法在奥美拉唑肠溶胶囊含量及有关物质检测中的应用
High Performance Liquid Chromatography Determination of the Contents and the Related Substances of Omeprazole Enteric-coated Capsule
-
目的:研制前列宁肠溶胶囊,确定其提取制备工艺,初步制订质量标准。
Objective : To preliminary research extract preparation and the quality control of Qianliening enteric-coated capsule .
-
国产红霉素肠溶胶囊与进口品相比的相对生物利用度为(100.59±19.47)%;
Dissolution of Enteric-coated Erythromycin Capsules by Spectrophotometry F0 - ∞( 100.59 ± 19.47 ) % respectively .
-
目的:评价受试制剂奥美拉唑肠溶胶囊与参比肠溶胶囊的人体生物等效性。
Objective : To evaluate the bioequivalence of omeprazole enteric-coated capsule and reference capsule in healthy volunteers .